Diabetes, COVID 19 and mucormycosis: Clinical spectrum and outcome in a tertiary care medical center in Western India
Top Cited Papers
- 3 July 2021
- journal article
- research article
- Published by Elsevier BV in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 15 (4), 102196
- https://doi.org/10.1016/j.dsx.2021.102196
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatmentMedical Mycology, 2018
- Mucormycosis in patients without cancer: a case series from A tertiary care hospital in South India.2013
- Healthcare-Associated MucormycosisClinical Infectious Diseases, 2012
- Pathogenesis of MucormycosisClinical Infectious Diseases, 2012
- Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007Clinical Microbiology & Infection, 2011
- How I treat mucormycosisBlood, 2011
- Endothelial dysfunction in diabetes mellitus2007
- Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported CasesClinical Infectious Diseases, 2005
- Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetesPublished by Oxford University Press (OUP) ,2004
- Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes.2003